Intravenous administration of lipopolysaccharide (LPS) to rats results
in multifocal, primarily midzonal hepatic necrosis. The hepatic injur
y is associated with inflammation and is dependent on neutrophils and
the coagulation system. After LPS injection into rats, plasma fibrinog
en concentration and numbers of blood platelets and leukocytes decreas
e. Results of our studies, using immunocytochemistry for the detection
of neutrophils and (111)indium-labeling to identify platelets, indica
te that both neutrophils and platelets accumulate within the liver ear
ly after administration of LPS to rats. The accumulation of platelets
in the liver before the onset of injury suggested that platelets contr
ibute to the manifestation of LPS-induced hepatotoxicity. To test this
hypothesis, the number of circulating blood platelets was decreased b
y the administration of an anti-rat platelet serum (APS) before LPS ad
ministration. The consequent thrombocytopenia by APS administration wa
s associated with an attenuation of both LPS-induced liver injury and
the activation of the coagulation system. However, the APS treatment d
id not prevent the hepatic neutrophil accumulation. These results sugg
est that platelets contribute to the pathogenesis of liver injury afte
r LPS administration, perhaps through their integral role in coagulati
on and/or interaction with neutrophils, but they do not appear to cont
ribute to hepatic neutrophil accumulation.